Business Wire

Kiromic BioPharma Welcomes Two New Directors to its Board

HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND ® artificial ...
Business Insider

Assessing Ambrx Biopharma: Insights From 7 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Ambrx Biopharma (NASDAQ:AMAM) in the last three months. The following table summarizes their ...
Business Insider

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology ...
Business Wire

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of KBI PUREplatform™, a premium microbial cell line development (CLD) platform that ...
U.S. News & World Report

Biopharma Industry Eyes 2025 Bounceback, Grapples With Uncertainty Over Trump Return

SAN FRANCISCO (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's priorities ...